ARGENT: Exploring nano solutions for cancer therapy

Vu-Long Tran: Development of Lanthanides based nanosensitizers for theragnostics
Kaspar Haume: Development of new modules for ATK code for modeling radiosensitizing nanoagents
Marta Bolsa: Improvement of the hadrontherapy protocols using nanosensitizers
Pablo de Vera: Multiscale understanding of radiation biodamage
翻墙vpn:2021-5-21 · 翻墙vpn 是塞 用小明上p站 quantumult 支不支持 ws tls download ultra vpn pan p站 看国际抖音用哪个加速器 百度学术精灵 LEAN 配置V2RAY 小水滴VPN 油管怎么下载app antss蚂蚁加速 ssr小飞机 官网 蚂蚁ant加速 破解版 vP推荐 魅族手机 ...


The FP7 European Multi-ITN (Marie Curie Actions Initial Training Network) project “Advanced Radiotherapy, Generated by Exploiting Nanoprocesses and Technologies (ITN ARGENT)” started in March 2014.

The main objective of this intersectorial and multidisciplinary ITN is to create a new generation of researchers and experts able to develop and propose to the society new tools and concepts for the improvement of cancer therapy treatments’’ The consortium aims to train a cohort of 13 PhDs (Early Stage Researchers – ESRs) to subsequently act as leaders and ambassadors in the field. The ITN ARGENT strategy relies on i) improving our understanding of the processes and mechanisms underlying radiation damage on a nanoscopic level, ii) applying the improved know-how in the production and development of functionalised nanodrugs to amplify the effects of medical beams and iii) developing of concepts and codes for clinical applications, taking into account the new information.Read more...